GH Research (GHRS) Revenue & Revenue Breakdown
GH Research Revenue Highlights
Latest Revenue (Q)
$80.00K
GH Research Revenue by Period
GH Research Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
GH Research generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
GH Research Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $80.00K | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
GH Research generated $80.00K in revenue during Q1 2024, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
GH Research Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| RCUS | Arcus Biosciences | $117.00M | $39.00M |
| RLAY | Relay Therapeutics | $25.55M | - |
| HOWL | Werewolf Therapeutics | $19.94M | $742.00K |
| IKNA | Ikena Oncology | $9.16M | - |
| STOK | Stoke Therapeutics | $8.78M | $4.22M |
| JANX | Janux Therapeutics | $8.08M | $1.25M |
| MOLN | Molecular Partners | $7.04M | $2.74M |
| MNOV | MediciNova | $1.00M | - |
| ANEB | Anebulo Pharmaceuticals | - | - |
| DSGN | Design Therapeutics | - | - |
| RZLT | Rezolute | - | - |
| CGEM | Cullinan Oncology | - | - |
| GPCR | Structure Therapeutics | - | - |
| GHRS | GH Research | - | $80.00K |
| PHVS | Pharvaris | - | - |
| CYT | Cyteir Therapeutics | - | - |
| ANNX | Annexon | - | - |
| ELYM | Eliem Therapeutics | - | - |
| PMVP | PMV Pharmaceuticals | - | - |
| MLYS | Mineralys Therapeutics | - | - |
| GLUE | Monte Rosa Therapeutics | - | $4.70M |
| PEPG | PepGen | - | - |
| CSBR | Champions Oncology | - | - |
GHRS Revenue FAQ
What is GH Research’s yearly revenue?
GH Research's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. GHRS's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is GH Research’s quarterly revenue?
GH Research's quarterly revenue for Q1 2024 was $80K, a 100.00% increase from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $0, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). GHRS's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).
What is GH Research’s revenue growth rate?
GH Research's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.